Lead sponsor
Biomea Fusion Inc.
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.
2
Trials led
2
Ongoing
140
Total enrollment
18
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 2
1
Trials by status
Recruiting
1
Active, not recruiting
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult ParticipantsBMI 25-40Ph 1Active, not recruiting80